A Non-Randomized Direct Comparison of Cognitive-Behavioral Short- and Long-Term Treatment for Binge Eating Disorder by Schlup, Barbara et al.
Original Article
Obes Facts 2010;3:261–266 Published online: August 6, 2010
DOI: 10.1159/000319538
Simone Munsch, Ph.D.
Department of Clinical Child and Adolescent Psychology 
Institute of Psychology, University of Lausanne
Anthropole 3127, 1015 Lausanne, Switzerland
Tel. +41 21 692 32-31, Fax -65
simone.munsch@unil.ch
© 2010 S. Karger GmbH, Freiburg
Accessible online at: 
www.karger.com/ofa
Fax +49 761 4 52 07 14
Information@Karger.de
www.karger.com
A Non-Randomized Direct Comparison of Cognitive- 
Behavioral Short- and Long-Term Treatment for Binge 
Eating Disorder
Barbara Schlupa  Andrea H. Meyera  Simone Munschb 
a Department of Clinical Psychology and Psychotherapy, Faculty of Psychology, University of Basel, 
b Department of Clinical Child and Adolescent Psychology, Institute of Psychology, University of Lausanne, Switzerland
Keywords
Quasi experiment · Binge eating disorder ·  
Treatment duration · CBT · Moderator
Summary
Background: To compare treatment outcomes of a 
cognitive-behavioral long-term (CBT-L) and short-term 
(CBT-S) treatment for binge eating disorder (BED) in a 
non-randomized comparison and to identify modera-
tors of treatment outcome. Methods: 76 female patients 
with BED participated in the study: 40 in CBT-L and 36 
in CBT-S. Outcome values were compared at the end 
of the active treatment phase (16 sessions for CBT-L, 8 
sessions for CBT-S) and at 12-month follow-up. Results: 
Both treatments produced significant reductions in binge 
eating. At the end of active treatment, but not at the end 
of follow-up, effects of primary outcomes (e.g. remission 
from binge eating, EDE shape concern) were better for 
CBT-L than for CBT-S. Dropout rates were significantly 
higher in CBT-L (35%) than in CBT-S (14%). Moderator 
analyses revealed that treatment efficacy for rapid re-
sponders and individuals exhibiting high scores on the 
mixed dietary negative affect subtype differed between 
the CBT-L and CBT-S with respect to objective binges, 
restraint eating and eating concern. Conclusion: Find-
ings suggest that CBT in general represents an effective 
treatment for BED, but that subgroups of patients might 
profit more from a prolonged treatment. Short, less- 
intensive CBT treatments could nevertheless be a viable 
option in the treatment of BED. 
Introduction
Cognitive-behavioral therapy (CBT) is the most researched 
and the best-supported treatment for binge eating disorder 
(BED) [1, 2]. Previous findings suggest that briefer, less costly 
interventions may be effective for at least a subset of patients 
with BED [2, 3]. Direct comparisons of brief and more inten-
sive treatments seem warranted, given the apparent respon-
siveness of BED to a wide range of treatment modalities [4]. 
In addition, research regarding factors influencing treatment 
outcome in BED is needed to develop more effective treat-
ments [5–9]. This way, patients suited for low-intensity treat-
ments could be more easily identified [9], thereby possibly 
improving the cost-effectiveness of treatment approaches for 
BED.
The aim of the present study was to compare the efficacy 
of a long-term and a short-term CBT treatment for individu-
als with BED. Both treatments have previously been evalu-
ated with equivalent study designs and have proven to be 
 efficacious for BED. Based on our previous findings of a 
marked reduction of binge eating within the first 8 weeks of 
the 16-session CBT [10] and the finding that the shortened in-
tervention was efficacious for BED [11], we wanted to test to 
what degree, if at all, the 16-week CBT outperformed the 
8-week CBT with respect to BED-relevant outcomes. 
A second goal of the present study was to examine poten-
tial moderators of treatment outcome. We aimed to examine 
whether i) rapid response to treatment [5, 7] and ii) high nega-
tive affect at pretreatment influenced the two CBT treatments 
differently. 
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For the number of self-reported binge episodes, participants filled out 
a record sheet monitoring the number of ‘episodes of overeating during 
which you felt out of control’ during the past week.
BMI
Weight and height were measured on a Seca electronic balance scale 
(Seca, Vogel and Halke, Hamburg, Germany) and by a stadiometer. 
BMI was  calculated as weight in kilograms divided by the square of 
height in  meters (kg/m2).
Suitability of Treatment
Suitability of treatment was assessed with the session protocol of Graweet 
al. [18]. Participants rated item 19 (‘I think another therapeutic procedure 
would be more suitable for me’) on a 7-point Likert scale ranging from –3 
(not at all) to +3 (yes, exactly). Ratings were assessed for each session 
during the active treatment phase and during follow-up.
Statistical Analyses
Comparison of the Two Treatments
Outcomes were remission from binge eating (based on EDE), number of 
OBEs (EDE), associated eating disorder psychopathology (four EDE 
subscales) and BMI. 
The complete datasets of both samples were available for analysis, 
making it possible to compare the two intervention programs over the 
treatment course. To analyze continuously distributed outcome measures, 
we used linear mixed models [12, 19]. In studies where missing values fre-
quently occur and if the absence only depends on observed and not on 
unobserved measurements (a so-called missing at random or MAR pat-
tern sensu [20]), linear mixed models have been shown to lead to more 
efficient and less biased results compared with complete case analyses or 
intent-to-treat analyses in which missing values have been imputed prior 
to the analysis using the last observation carried forward (LOCF) 
method. Also, results based on the LOCF method can be biased in either 
direction and thus can be interpreted as being conservative or liberal [21]. 
To analyze dichotomous outcome measures we applied a logistic-normal 
model representing a special case of a generalized linear mixed model 
(GLMM) in which the random effects structure is reduced to a random 
intercept only [22]. In cases where the predicted values of the dichoto-
mous outcomes were close to 0 or 1, rendering the computation of esti-
mates problematic, we used in addition Fisher’s exact test to compare 
treatments at each measurement point. The statistical models contained 
the treatment (CBT-L vs. CBT-S) as a between- and time as a within-
subjects factors. Predicted mean outcome values based on the mixed 
model/GLMM were compared between the two treatments at the end of 
treatment and end of follow-up. Effect sizes according to Cohen [23] for 
continuous variables, or Odds ratios for dichotomous variables, were cal-
culated at the end of treatment and at the end of follow-up. To indicate 
statistical significance, an alpha level of 0.05 was chosen, unless otherwise 
specified. Analyses were done using the software programs R 2.5 [24] and 
SPSS for Windows 14 (SPPS, Chicago, IL, USA). For generalized linear 
mixed models we used in addition the R packages lme4 [25] and glmmML 
[26].
Moderator Analyses
A significant pretreatment variable × treatment (here: short vs. long) in-
teraction indicates that the pretreatment variable is a potential moderator 
[27]. We also tested for the interaction pretreatment variable × treatment × 
time to include the temporal aspect of the study but never obtained any 
significant result. Therefore, we here focus on the results based on the 
two-way interaction. Based on the literature, the following two pretreat-
ment variables were included into the analyses: 
Participants and Methods
Participants
Participants were drawn from two different samples, both originating from 
studies conducted at the University of Basel, Switzerland. One sample 
(N = 40) included obese participants from a treatment trial evaluating the 
efficacy of a CBT program consisting of 16 sessions [12] that had been 
conducted during the period of 2001 to 2003 (referred to as CBT-L). The 
other sample (N = 36) was drawn from a study evaluating the efficacy of a 
short-term CBT with 8 sessions in a waitlist-controlled design [11] that had 
been conducted during the period of December 2004 to June 2007 (re-
ferred to as CBT-S). The CBT-S included participants from both the im-
mediate treatment and the 8-week waitlist condition, as prior analyses had 
shown that there were no differences between those groups. Inclusion and 
exclusion criteria were identical for both samples (consider Munsch et al. 
[10] and Schlup et al. [11] for further information). Participant characteris-
tics and comparisons of the two samples are shown in table 1.
Treatment Protocols
CBT-L
The efficacy of the CBT-L was demonstrated by Munsch et al. [10]. The 
protocol included 16 weekly 90-min group sessions in the active treatment 
phase and 5 booster sessions during the 12-month follow-up period. During 
these sessions, treatment contents discussed during the active treatment 
phase were revised, whereas no new treatment topics were introduced. 
CBT-S
CBT-S is a shortened version of the CBT-L and has proven efficacy in a 
prior study [11]. There were 8 weekly 90-min group sessions in the active 
treatment phase, followed by 5 group sessions identical to the CBT-L 
during follow-up treatment. The protocol mainly focused on reducing the 
core symptomatology of BED. In contrast to the longer version, psycho-
education on balanced nutrition and modification of body concept were 
only marginally targeted (for the content of the two treatment protocols 
please consider Munsch et al. [10] and Schlup et al. [11]). 
Treatment groups in both samples started when 5–8 participants had 
been recruited. In both samples there were seven treatment groups car-
ried through by fully qualified psychotherapists with specialized training 
in CBT and master’s students of clinical psychology as co-therapists. 
Therapists and co-therapists in both studies were trained and supervised 
weekly by the senior researchers of the corresponding study (B.S. and 
S.M.).
Assessments and Procedures
Variables were assessed at pretreatment, at the end of treatment (i.e., fol-
lowing 16 weeks of CBT in the CBT-L sample and following 8 weeks of 
CBT in the CBT-S sample) and at 12-month follow-up. The number of 
self-reported binge episodes was assessed weekly during the active treat-
ment phase (i.e., 8 times for the CBT-S and 16 times for the CBT-L) and 
at 3-, 6-, and 12-month follow-up.
Diagnostic Interviews
Screenings for current and lifetime mental disorders according to DSM-
IV-TR in the German language were conducted at pretreatment and 
 included structured diagnostic interviews for mental disorders on Axis I 
[13] and Axis II [14]. 
Eating Disorder Psychopathology
BED diagnosis relied on DSM-IV-TR research criteria for BED and was 
confirmed with the Eating Disorder Examination Interview (EDE) [15, 
16], a semi-structured interview with established reliability [17] and sensi-
tivity to track changes in eating disorder psychopathology [16]. The EDE 
assesses features of BED, such as the number of objective binge episodes 
(OBEs) i.e. binge eating defined as consuming unusually large quantities 
of food with a subjective sense of loss of control, and abstainer rates (‘re-
mission’), i.e. proportion of patients not experiencing a binge during the 
last 28 days. In addition, the EDE comprises four subscales: dietary re-
straint, eating concern, weight concern and shape concern. Items are 
rated on a 7-point forced-choice scale (0–6), with higher scores reflecting 
greater severity or frequency of eating disorder psychopathology. 
CBT-L
(n = 40)
CBT-S
(n = 36)
Test statistics and  
significance
Mean age, years (SD)  44.6 (11.2)  44.4 (10.2) t74 = 0.10, p = 0.921
Mean age at onset of disorder, years (SD)  30.4 (14.7)  25.2 (12.1) t64 = 1.56, p = 0.124
Mean BMI, kg/m2 (SD)  33.2 (4.3)  33.2 (6.9) t72 = –0.13, p = .988
Percentage of participants
 With high school degree 100 100 –
 With college education  17.5  20.1 c21 = 1.901, p = 0.168 
 Employed  79.5  85.4 c21 = 0.495, p = 0.482 
 Married or cohabiting with partner  77.3  61.0 c21 = 2.655, p = 0.103 
Number (%) of participants
 With current comorbidity Axis I  19 (61.3%)  12 (33.3%) c21 = 0.809, p = 0.368
 Depression   5 (11.4%)   4 (11.1%) c21 = 0.001, p = 0.972
 Anxiety disorders  13 (29.5%)  10 (27.8%) c21 = 0.030, p = 0.862 
 Lifetime comorbidity Axis I  32 (72.7%)  19 (52.8%) c21 = 3.410, p = 0.065
 Depression  19 (43.2%)  12 (33.3%) c21 = 0.809, p = 0.368
 Anxiety disorders  13 (29.5%)   8 (22.2%) c21 = 0.549, p = 0.459
 Comorbidity Axis II   5 (11.4%)   2 (5.6%) c21 = 0.837, p = 0.360
CBT-L = 16-session CBT; CBT-S = 8-session CBT.
aCurrent and lifetime diagnoses according to DSM-IV-TR were assessed using structured clinical 
 interviews for Axis I [13] and Axis II [14] disorders.
Table 1. Sample characteristics at baselinea
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i) Rapid response to treatment according to [7, 28], defined on the basis 
of the weekly self-monitoring records of binge eating. According to 
the definition of rapid response used by other authors [5], patients 
with a 65% or more decrease in binge eating within the first 4 weeks 
were considered rapid responders. We used linear mixed models to 
estimate the decrease in binge eating within the first 4 weeks as this 
allowed us to obtain estimates also for patients with missing values 
within that period. Rapid response was then used as a potential mod-
erator of treatment outcome. 
ii) Mixed dietary-negative affect subtype, assessed according to the sugges-
tions by [29–31]. The variable in our study was derived by cluster analy-
sis from BDI, BAI and the EDE subscale dietary restraint. Participants’ 
scores on these variables were submitted to a K-means  cluster analysis 
using the Quick Cluster algorithm from SPSS 14. Outcomes were the 
number of objective binges as well as the four EDE subscales dietary 
restraint, eating concern, weight concern, and shape concern. 
The statistical models used were the same as for the comparison of the 
two treatments except that the moderator variable of interest was in-
cluded here as a main effect and in all interaction terms.
Results
Dropouts
Dropout rates differed between the two samples, with signifi-
cantly more dropouts in the CBT-L (14, or 35% of all partici-
pants) than in the CBT-S (5, or 14% of all participants) be-
tween baseline and 12-month follow-up (p = 0.034; c2 test). In 
the CBT-L the majority of participants (12, or 30% of all par-
ticipants) withdrew from treatment during the 16 weeks active 
treatment, in contrast to only one (2.8%) participant during 
the 8 weeks active treatment of CBT-S (p = 0.002). The rea-
sons for dropouts included dissatisfaction with treatment (n = 
6), lack of time (n = 2), major depression (n = 1) and other 
reasons (n = 3) in the CBT-L, and dissatisfaction (n = 1) in the 
CBT-S. During the 12-month follow-up period, there were no 
significant differences in the dropout rates between the two 
samples (2, or 5%, and 4, or 11% of all participants in the 
CBT-L and CBT-S, respectively; p = 0.32).
Compliance and Suitability
Participants attended on average 13.2 ± 2.2 (mean ± SE), or 
82% of the 16 sessions in the CBT-L, and 6.6 ± 1.4, or 82% of 
the 8 sessions in the CBT- S. During the follow-up period of 5 
booster sessions in both samples, participants in the CBT-L 
were present at 3.9 ± 1.5, or 78%, and participants in the 
CBT-S at 3.2 ± 1.3, or 65% of the sessions. No significant 
 differences in compliance were found between the CBT-L 
and CBT-S samples (p = 0.95 for the active treatment phase, 
p = 0.074 for the follow-up phase; c2 test). 
At the beginning and at the end of treatment, patients in 
the CBT-S gave significantly better ratings of suitability of 
treatment (–1.3; –1.7) than patients in the CBT-L (–0.4; –0.9; 
p < 0.05 for both tests), but not at the end of follow-up (–1.5 
for CBT-L, –0.9 for CBT-S, p = 0.29).
For the number of self-reported binge episodes, participants filled out 
a record sheet monitoring the number of ‘episodes of overeating during 
which you felt out of control’ during the past week.
BMI
Weight and height were measured on a Seca electronic balance scale 
(Seca, Vogel and Halke, Hamburg, Germany) and by a stadiometer. 
BMI was  calculated as weight in kilograms divided by the square of 
height in  meters (kg/m2).
Suitability of Treatment
Suitability of treatment was assessed with the session protocol of Graweet 
al. [18]. Participants rated item 19 (‘I think another therapeutic procedure 
would be more suitable for me’) on a 7-point Likert scale ranging from –3 
(not at all) to +3 (yes, exactly). Ratings were assessed for each session 
during the active treatment phase and during follow-up.
Statistical Analyses
Comparison of the Two Treatments
Outcomes were remission from binge eating (based on EDE), number of 
OBEs (EDE), associated eating disorder psychopathology (four EDE 
subscales) and BMI. 
The complete datasets of both samples were available for analysis, 
making it possible to compare the two intervention programs over the 
treatment course. To analyze continuously distributed outcome measures, 
we used linear mixed models [12, 19]. In studies where missing values fre-
quently occur and if the absence only depends on observed and not on 
unobserved measurements (a so-called missing at random or MAR pat-
tern sensu [20]), linear mixed models have been shown to lead to more 
efficient and less biased results compared with complete case analyses or 
intent-to-treat analyses in which missing values have been imputed prior 
to the analysis using the last observation carried forward (LOCF) 
method. Also, results based on the LOCF method can be biased in either 
direction and thus can be interpreted as being conservative or liberal [21]. 
To analyze dichotomous outcome measures we applied a logistic-normal 
model representing a special case of a generalized linear mixed model 
(GLMM) in which the random effects structure is reduced to a random 
intercept only [22]. In cases where the predicted values of the dichoto-
mous outcomes were close to 0 or 1, rendering the computation of esti-
mates problematic, we used in addition Fisher’s exact test to compare 
treatments at each measurement point. The statistical models contained 
the treatment (CBT-L vs. CBT-S) as a between- and time as a within-
subjects factors. Predicted mean outcome values based on the mixed 
model/GLMM were compared between the two treatments at the end of 
treatment and end of follow-up. Effect sizes according to Cohen [23] for 
continuous variables, or Odds ratios for dichotomous variables, were cal-
culated at the end of treatment and at the end of follow-up. To indicate 
statistical significance, an alpha level of 0.05 was chosen, unless otherwise 
specified. Analyses were done using the software programs R 2.5 [24] and 
SPSS for Windows 14 (SPPS, Chicago, IL, USA). For generalized linear 
mixed models we used in addition the R packages lme4 [25] and glmmML 
[26].
Moderator Analyses
A significant pretreatment variable × treatment (here: short vs. long) in-
teraction indicates that the pretreatment variable is a potential moderator 
[27]. We also tested for the interaction pretreatment variable × treatment × 
time to include the temporal aspect of the study but never obtained any 
significant result. Therefore, we here focus on the results based on the 
two-way interaction. Based on the literature, the following two pretreat-
ment variables were included into the analyses: 
Treatment groups in both samples started when 5–8 participants had 
been recruited. In both samples there were seven treatment groups car-
ried through by fully qualified psychotherapists with specialized training 
in CBT and master’s students of clinical psychology as co-therapists. 
Therapists and co-therapists in both studies were trained and supervised 
weekly by the senior researchers of the corresponding study (B.S. and 
S.M.).
Assessments and Procedures
Variables were assessed at pretreatment, at the end of treatment (i.e., fol-
lowing 16 weeks of CBT in the CBT-L sample and following 8 weeks of 
CBT in the CBT-S sample) and at 12-month follow-up. The number of 
self-reported binge episodes was assessed weekly during the active treat-
ment phase (i.e., 8 times for the CBT-S and 16 times for the CBT-L) and 
at 3-, 6-, and 12-month follow-up.
Diagnostic Interviews
Screenings for current and lifetime mental disorders according to DSM-
IV-TR in the German language were conducted at pretreatment and 
 included structured diagnostic interviews for mental disorders on Axis I 
[13] and Axis II [14]. 
Eating Disorder Psychopathology
BED diagnosis relied on DSM-IV-TR research criteria for BED and was 
confirmed with the Eating Disorder Examination Interview (EDE) [15, 
16], a semi-structured interview with established reliability [17] and sensi-
tivity to track changes in eating disorder psychopathology [16]. The EDE 
assesses features of BED, such as the number of objective binge episodes 
(OBEs) i.e. binge eating defined as consuming unusually large quantities 
of food with a subjective sense of loss of control, and abstainer rates (‘re-
mission’), i.e. proportion of patients not experiencing a binge during the 
last 28 days. In addition, the EDE comprises four subscales: dietary re-
straint, eating concern, weight concern and shape concern. Items are 
rated on a 7-point forced-choice scale (0–6), with higher scores reflecting 
greater severity or frequency of eating disorder psychopathology. 
CBT-L
(n = 40)
CBT-S
(n = 36)
Test statistics and  
significance
Mean age, years (SD)  44.6 (11.2)  44.4 (10.2) t74 = 0.10, p = 0.921
Mean age at onset of disorder, years (SD)  30.4 (14.7)  25.2 (12.1) t64 = 1.56, p = 0.124
Mean BMI, kg/m2 (SD)  33.2 (4.3)  33.2 (6.9) t72 = –0.13, p = .988
Percentage of participants
 With high school degree 100 100 –
 With college education  17.5  20.1 c21 = 1.901, p = 0.168 
 Employed  79.5  85.4 c21 = 0.495, p = 0.482 
 Married or cohabiting with partner  77.3  61.0 c21 = 2.655, p = 0.103 
Number (%) of participants
 With current comorbidity Axis I  19 (61.3%)  12 (33.3%) c21 = 0.809, p = 0.368
 Depression   5 (11.4%)   4 (11.1%) c21 = 0.001, p = 0.972
 Anxiety disorders  13 (29.5%)  10 (27.8%) c21 = 0.030, p = 0.862 
 Lifetime comorbidity Axis I  32 (72.7%)  19 (52.8%) c21 = 3.410, p = 0.065
 Depression  19 (43.2%)  12 (33.3%) c21 = 0.809, p = 0.368
 Anxiety disorders  13 (29.5%)   8 (22.2%) c21 = 0.549, p = 0.459
 Comorbidity Axis II   5 (11.4%)   2 (5.6%) c21 = 0.837, p = 0.360
CBT-L = 16-session CBT; CBT-S = 8-session CBT.
aCurrent and lifetime diagnoses according to DSM-IV-TR were assessed using structured clinical 
 interviews for Axis I [13] and Axis II [14] disorders.
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different CBT formats for BED, but not for obesity [for re-
view see 32]. 
The temporal course of binge eating in both treatments 
was characterized by marked improvements at the beginning 
of treatment that were maintained until the end of follow-up. 
Specific comparisons of treatment outcomes at different 
measurement points throughout the study suggest that the 
CBT-L produced better outcomes than the CBT-S, especially 
at the end of the active treatment phase, i.e. after 8 weeks of 
treatment for CBT-S and after 16 weeks of treatment for 
CBT-L. Results of the secondary analyses thus underlined the 
relative superiority of the CBT-L over the CBT-S at the end 
of treatment and, to a lesser extent, at the end of follow-up. 
An important issue in this respect, however, is the signifi-
cantly higher dropout rate in the CBT-L (35%) compared to 
that in the CBT-S (14%). Since there were no statistically sig-
nificant differences in baseline characteristics between the 
CBT-L and the CBT-S (e.g. age, age of onset of disorder, 
BMI, education level, or current or lifetime comorbidity 
rates), these factors are unlikely to influence the higher drop-
out rates in the CBT-L. It could be argued, however, that the 
dropouts may be related to the length of treatment itself, 
given that the reasons for dropout were dissatisfaction with 
treatment for six participants in CBT-L, compared to only 
one participant being dissatisfied with treatment in CBT-S. 
Slightly more than half of our study sample was classified as 
rapid responders. Treatment efficacy for OBEs was higher for 
rapid responders than non-rapid responders in CBT-S, 
whereas in CBT-L effects for both rapid and non-rapid re-
sponders were similar and also comparable to the effect of re-
sponders in the CBT-S. This suggests that within the shorter 
treatment option, patients’ capacity to benefit from interven-
tions early in treatment course is important, whereas in the 
CBT-L patients similarly profit from treatment until the 16th 
session, independent of the rapid response status. Longer 
treatment resulted in a better outcome in terms of EDE die-
tary restraint in rapid responders, whereas in CBT-S both 
rapid and non-rapid responders had almost identical values 
that were higher than those for rapid responders in CBT-L. It 
could therefore be hypothesized that core features of eating 
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ers had values for the EDE subscale dietary restraint that 
were on average much lower than those of the non-respond-
ers (1.47 vs. 2.06) in the CBT-L but almost identical in the 
CBT-S (1.88 for both responders and non-responders; interac-
tion rapid response × sample, p = 0.047). 
Mixed Dietary-Negative Affect Subtype
Cluster analyses with the BDI, the BAI and the EDE subscale 
dietary restraint (EDEres) revealed two different clusters. 
The majority of participants (72%) belonged to the high 
mixed dietary negative affect (mean values: BDI = 26.7 ± 8.1, 
BAI = 23.8 ± 9.3, EDEres = 2.31 ± 1.21), and 28% to the low 
mixed dietary negative affect subtype (mean values: BDI = 
9.3 ± 5.6, BAI = 6.0 ± 4.5, EDEres = 2.06 ± 0.99). Percentages 
in the two clusters did not differ between the two treatments 
(c2 = 0.89, p = 0.35). In the CBT-S subjects of the high mixed 
dietary negative affect subtype had higher values for the EDE 
subscale eating concern than those of low subtype (1.79 vs. 
0.93), whereas the corresponding values in the CBT-L were 
quite similar (low subtype: 1.15, high subtype: 0.98; interac-
tion subtype × sample, p = 0.021). 
Discussion
This study examined a non-randomized direct comparison of 
a longer CBT comprising 16 sessions (CBT-L), with a short-
ened CBT consisting of 8 sessions (CBT-S). Both treatments 
were followed by booster sessions until 12-month follow-up. 
Overall, these findings underline the established efficacy of 
Comparison of the Two Treatments
Table 2 provides the predicted means for all outcomes of the 
two treatments at baseline, end of treatment and end of fol-
low-up. 
The percentage of remission was significantly higher for 
CBT-L than for CBT-S at the end of treatment, but not so at 
the end of follow-up (based on GLMM). In contrast, Fisher’s 
exact test performed at separate measurement points and for 
the available cases only gave significantly higher values for 
CBT-L than for CBT-S at both end of treatment (p = 0.006) 
and end of follow-up (p = 0.007). Treatment means for OBEs 
and BMI were both very similar between CBT-S and CBT-L 
and did not significantly differ during treatment course. With 
respect to eating disorder pathology, CBT-S revealed slightly 
better results, but significant differences between CBT-S and 
CBT-L were only found for EDE shape concern at the end of 
treatment. 
Moderator Analyses
Rapid Response
55% of all participants were classified as rapid responders. 
This percentage did not differ between the two treatments 
(c2 = 0.61, p = 0.44). Averaged across the study period, rapid 
responders had lower values for OBEs in the CBT-S than 
non-responders (6.1 vs. 8.5), whereas in the CBT-L these two 
values were comparable (responders: 6.6, non-responders: 6.3; 
interaction rapid response × sample, p = 0.023). Also respond-
Table 2. Treatment outcome variables in the CBT-L and the CBT-S at baseline, end of treatment, and end of follow-upa
Baseline End of treatment End of follow-up
CBT-L CBT-S CBT-L CBT-S CBT-L CBT-S
Remission,% (EDE) 0
(n = 39)
0
(n = 30)
– 86
(n = 24)
46
(n = 27)
p = 0.008
OR = 7.4
>99
(n = 15)
64
(n = 20)
p = 0.16
OR = 127.4
Objective binge episodes 
(EDE)
14.80
(n = 39)
14.80
(n = 30)
p = 0.98
ES = 0.004
0.43
(n = 24)
2.36
(n = 27)
p = 0.23
ES = 0.29
0.01
(n = 15)
1.91
(n = 20)
p = 0.43
ES = 0.16
Dietary Restraint (EDE) 2.19
(n = 40)
2.08
(n = 36)
p = 0.70
ES = 0.06
1.01
(n = 24)
1.62
(n = 33)
p = 0.06
ES = 0.30
1.05
(n = 15)
1.75
(n = 28)
p = 0.07
ES = 0.29
Shape concern (EDE) 3.95
(n = 40)
3.51
(n = 36)
p = 0.16
ES = 0.25
2.15
(n = 24)
3.00
(n = 33)
p = 0.02
ES = 0.39
1.91
(n = 15)
2.58
(n = 28)
p = 0.10
ES = 0.25
Weight concern (EDE) 3.64
(n = 40)
3.39
(n = 36)
p = 0.39
ES = 0.14
2.14
(n = 24)
2.52
(n = 33)
p = 0.27
ES = 0.17
1.66
(n = 15)
2.26
(n = 28)
p = 0.14
ES = 0.23
Eating concern (EDE) 1.91
(n = 40)
1.73
(n = 36)
p = 0.44
ES = 0.13
0.34
(n = 24)
0.82
(n = 33)
p = 0.07
ES = 0.29
0.16
(n = 15)
0.68
(n = 28)
p = 0.09
ES = 0.26
BMI 33.14
(n = 40)
33.36
(n = 36)
p = 0.87
ES = 0.04
33.13
(n = 28)
33.15
(n = 32)
p = 0.98
ES = 0.005
32.24
(n = 23)
32.63
(n = 27)
p = 0.79
ES = 0.06
ES = Effect size according to Cohen (for continuous outcomes); OR = odds ratio (for dichotomous outcomes). 
aMeans denote estimates from a linear mixed model or generalized linear mixed model. Values were back-transformed if necessary.
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disorder pathology could efficaciously be improved within a 
prolonged time span. 
The majority of the patients belonged to the mixed dietary 
negative affect subtype (72%). This moderator only influ-
enced treatment success within CBT-S and only with respect 
to eating concern. Subjects of high negative subtype were the 
least successfully treated and hence should better be treated 
using a prolonged treatment option. However, as we did not 
find any further moderating effects for other outcomes, the 
interpretation of this result should also take into account the 
possibility of chance effects.
As limitations to the present study most importantly the 
nonrandomized design has to be addressed. Although the two 
studies were conducted in very comparable settings consider-
ing specific and nonspecific factors (e.g. patient characteristics, 
therapist effects), only a direct, randomized comparison of the 
two treatments within the same setting and patients sample 
and conducted by the same staff could minimize the effects of 
uncontrolled factors (e.g. different therapists, self-selection 
bias because patients knew about the length of treatment). 
Second, the statistical power was weak because of the rather 
small sample size; therefore, it is possible that we were unable 
to detect further meaningful differences between the two 
treatments. Third, inferences about between-group differences 
are limited by the fact that many missing values occurred, par-
ticularly with respect to data at the end of follow-up. 
Bearing the before mentioned limitations in mind, our 
findings indicate that CBT, whether short- or long-term, was 
an effective treatment for the majority of patients. We have 
demonstrated that patients classified as non-rapid responders 
or those exhibiting high scores on the mixed dietary negative 
affect subtype benefit from prolonged treatment options with 
respect to eating disorder pathology. Future research should 
re-evaluate these preliminary findings thereby taking into 
 account long-term outcome.
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different CBT formats for BED, but not for obesity [for re-
view see 32]. 
The temporal course of binge eating in both treatments 
was characterized by marked improvements at the beginning 
of treatment that were maintained until the end of follow-up. 
Specific comparisons of treatment outcomes at different 
measurement points throughout the study suggest that the 
CBT-L produced better outcomes than the CBT-S, especially 
at the end of the active treatment phase, i.e. after 8 weeks of 
treatment for CBT-S and after 16 weeks of treatment for 
CBT-L. Results of the secondary analyses thus underlined the 
relative superiority of the CBT-L over the CBT-S at the end 
of treatment and, to a lesser extent, at the end of follow-up. 
An important issue in this respect, however, is the signifi-
cantly higher dropout rate in the CBT-L (35%) compared to 
that in the CBT-S (14%). Since there were no statistically sig-
nificant differences in baseline characteristics between the 
CBT-L and the CBT-S (e.g. age, age of onset of disorder, 
BMI, education level, or current or lifetime comorbidity 
rates), these factors are unlikely to influence the higher drop-
out rates in the CBT-L. It could be argued, however, that the 
dropouts may be related to the length of treatment itself, 
given that the reasons for dropout were dissatisfaction with 
treatment for six participants in CBT-L, compared to only 
one participant being dissatisfied with treatment in CBT-S. 
Slightly more than half of our study sample was classified as 
rapid responders. Treatment efficacy for OBEs was higher for 
rapid responders than non-rapid responders in CBT-S, 
whereas in CBT-L effects for both rapid and non-rapid re-
sponders were similar and also comparable to the effect of re-
sponders in the CBT-S. This suggests that within the shorter 
treatment option, patients’ capacity to benefit from interven-
tions early in treatment course is important, whereas in the 
CBT-L patients similarly profit from treatment until the 16th 
session, independent of the rapid response status. Longer 
treatment resulted in a better outcome in terms of EDE die-
tary restraint in rapid responders, whereas in CBT-S both 
rapid and non-rapid responders had almost identical values 
that were higher than those for rapid responders in CBT-L. It 
could therefore be hypothesized that core features of eating 
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